STAB1 and neoplasm: Despite these cautions, targeting STAB1 represents a promising strategy for enhancing anti-tumor immunity by simultaneously modulating macrophage function and improving T-cell activation and cytotoxicity as represented in Figure 1 and outlined in Table 3.